About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds

Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds

NCT02607670·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Michael S Singer, MD, PhD
CONTACT
volunteers@topokine.com

Lead

Topokine Therapeutics, Inc.

Age

35–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Moderate to severe, bilateral nasolabial folds
Must understand and provide informed consent

You may not be if

Pregnant or lactating women
History of skin hypersensitivity of atopic dermatitis
Any illness of disease that, in the investigator's opinion, would make trial participation inadvisable

The record

StatusUnknown

PhasePhase 2

Taking part111

StartedJan 2016

UpdatedJan 5, 2016

Conditions

Nasolabial Folds

Where1

Topokine Research Site
Boston, Massachusetts, United States